Latest filing published 18 Feb 2026 for C4 Therapeutics, Inc..
No signal scores available.
Paige Mahaney is a declared insider of C4 Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 28 October 2024 to 14 February 2026, the count stands at 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 18 February 2026 with an option exercise in C4 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations